Thymopentin Completed Phase 2 Trials for Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00002332A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other Anti-HIV Drugs